Search

everythinglearnresearchcommunity

for

Search:↓

UC.145 may be a new biomarker for predicting gastric cancer.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

Less differentiated melanoma cells are more vulnerable to a type of cell death, which could improve cancer treatments.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Low zinc levels may be linked to the return of gynecologic cancers.

Reducing out-of-pocket costs increased colorectal cancer screenings.

Social media can motivate young Polish adults to visit a dermatologist.

Diabetes may lower the risk of prostate cancer.

Ultrasound-based radiomics and radiogenomics can improve ovarian cancer diagnosis and treatment, but need better standardization and AI tools.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Elaine Fuchs' research shows how skin stem cells maintain health, aid in healing, and are involved in cancer.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Non-invasive methods can effectively monitor skin inflammation and cancer biomarkers.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Frequent use of chemical hair relaxers may increase endometrial cancer risk in Black women.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Cancer patients in sub-Saharan Africa face significant challenges during chemotherapy, highlighting the need for better patient care and support.